Education
About Us
Working with TipRanks
Follow Us
Cresco Labs (TSE:CL)
:CL
CL Stock Chart & Stats
C$1.63
-C$0.07(-4.76%)
At close: 4:00 PM EST
C$1.63
-C$0.07(-4.76%)
Day’s Range― - ―
52-Week RangeC$0.60 - C$2.55
Previous CloseN/A
Volume48.59K
Average Volume (3M)344.83K
Market Cap
$1.21B
Enterprise ValueC$1.22B
Total Cash (Recent Filing)$45.41M
Total Debt (Recent Filing)$580.76M
Price to Earnings (P/E)―
Beta2.27
Next Earnings
Mar 18, 2026EPS Estimate
-0.02Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.07
Shares Outstanding340,486,820
10 Day Avg. Volume522,746
30 Day Avg. Volume344,826
Financial Highlights & Ratios
PEG Ratio0.07
Price to Book (P/B)0.66
Price to Sales (P/S)0.43
P/FCF Ratio2.89
Enterprise Value/Market Cap1.01
Enterprise Value/Revenue1.82
Enterprise Value/Gross Profit3.76
Enterprise Value/Ebitda10.88
Forecast
1Y Price Target
$2.43Price Target Upside48.85% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
EarningsBetter-than-expected gross margins driving EBITDA slightly ahead of forecast.
Financial PerformanceAdjusted EBITDA of $39.8M was above the estimate of $36.0M.
International ExpansionCresco announced that it will be entering international markets with plans to launch its branded flower into Germany.
Bears Say
Margin ExpectationsManagement expects margins to return to Q1 levels for the second half of the year.
Revenue DeclineRevenue of $163.6M was down 1.3% sequentially and down 11.2% year-over-year.
Cresco Labs News
CL FAQ
What was Cresco Labs’s price range in the past 12 months?
Cresco Labs lowest stock price was C$0.60 and its highest was C$2.55 in the past 12 months.
What is Cresco Labs’s market cap?
Cresco Labs’s market cap is $1.21B.
When is Cresco Labs’s upcoming earnings report date?
Cresco Labs’s upcoming earnings report date is Mar 18, 2026 which is in 88 days.
How were Cresco Labs’s earnings last quarter?
Cresco Labs released its earnings results on Nov 05, 2025. The company reported -C$0.069 earnings per share for the quarter, missing the consensus estimate of -C$0.043 by -C$0.026.
Is Cresco Labs overvalued?
According to Wall Street analysts Cresco Labs’s price is currently Undervalued.
Does Cresco Labs pay dividends?
Cresco Labs does not currently pay dividends.
What is Cresco Labs’s EPS estimate?
Cresco Labs’s EPS estimate is -0.02.
How many shares outstanding does Cresco Labs have?
Cresco Labs has 340,486,820 shares outstanding.
What happened to Cresco Labs’s price movement after its last earnings report?
Cresco Labs reported an EPS of -C$0.069 in its last earnings report, missing expectations of -C$0.043. Following the earnings report the stock price went up 3.311%.
Which hedge fund is a major shareholder of Cresco Labs?
Currently, no hedge funds are holding shares in TSE:CL
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Cresco Labs Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$2.43 (48.85% Upside)
$2.43 (48.85% Upside)
Blogger Sentiment
Bullish
TSE:CL Sentiment 100%
Sector Average 68%
Sector Average 68%
Insider Transactions
Sold Shares
Worth $10.3M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 3.6%
Last 30 Days ▲ 7.3%
Last 30 Days ▲ 7.3%
Technicals
SMA
Positive
20 days / 200 days
Momentum
84.43%
12-Months-Change
Fundamentals
Return on Equity
-11.79%
Trailing 12-Months
Asset Growth
-7.42%
Trailing 12-Months
Company Description
Cresco Labs
Cresco Labs Inc., together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co. brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand, as well as cannabis products under the Reserve brand. The company also offers cannabis flowers under the FloraCal brand; and chocolate and toffee confections, fruit-forward gummies, hard sweets, and taffy under the Mindy's Edibles brand, as well as licenses the Kiva brand, which produces cannabis infused edibles, including chocolate confections, gummies, mints, and tarts. In addition, the company offers cannabis-infused edibles under the Sunnyside brand. As of December 6, 2022, it owned and operated 55 dispensaries. The company was founded in 2013 and is headquartered in Chicago, Illinois.
CL Company Deck
CL Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted Cresco Labs' stable financial performance and strategic market expansions, including debt refinancing and market gains in Ohio and Germany. However, ongoing challenges such as price compression and the impact of higher cost flower on margins, along with the exit from California operations, presented notable lowlights.View all TSE:CL earnings summariesCL Stock 12 Month Forecast
Average Price Target
C$2.43
▲(48.85% Upside)
Technical Analysis
Cronos Group
―
Curaleaf Holdings
―
Green Thumb Industries
―
Trulieve Cannabis
―
Verano Holdings
―
Options Prices
Currently, No data available
---